Skip to main content
. 2024 May 25;6(8):101125. doi: 10.1016/j.jhepr.2024.101125

Table 4.

Multivariate Cox regression analysis for all patients (continuous variables) (n = 754).

Covariate Multivariate analysis
HR 95% CI p value
BCA parameters
AFP Continuous 1.0 1.0–1.1 0.347
Albumin Continuous 0.6 0.5–0.7 <0.001
Bilirubin Continuous 1.2 1.1–1.3 <0.001
AST level Continuous 1.1 1.0–1.2 0.003
INR level Continuous 1.0 0.9–1.1 0.524
Tumor number Continuous 1.1 1.0–1.2 0.116
Max. lesion size Continuous 1.3 1.1–1.5 <0.001
SM normalized Continuous 0.9 0.8–1.0 0.039
TAT normalized Continuous 1.0 1.0–1.0 0.424
SAT normalized
Continuous
1.0
1.0–1.0
0.349
BCA parameters/Bone
AFP Continuous 1.0 1.0–1.1 0.306
Albumin Continuous 0.6 0.5–0.7 <0.001
Bilirubin Continuous 1.2 1.1–1.3 <0.001
AST level Continuous 1.1 1.0–1.2 0.005
INR level Continuous 1.0 0.9–1.1 0.686
Tumor number Continuous 1.1 1.0–1.2 0.044
Max. lesion size Continuous 1.3 1.1–1.5 <0.001
SM/Bone Continuous 0.9 0.8–1.0 0.036
TAT/Bone
Continuous
1.0
0.9–1.1
0.985
Sarcopenia marker
AFP Continuous 1.0 1.0–1.1 0.309
Albumin Continuous 0.6 0.5–0.7 <0.001
Bilirubin Continuous 1.2 1.1–1.3 <0.001
AST level Continuous 1.1 1.0–1.2 0.006
INR level Continuous 1.0 0.9–1.1 0.694
Tumor number Continuous 1.1 1.0–1.2 0.044
Max. lesion size Continuous 1.3 1.1–1.5 <0.001
Sarcopenia marker Continuous 0.9 0.8–1.0 0.030

p values in bold show significant values.

AFP, alpha fetoprotein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; IMAT, intermuscular adipose tissue; INR, international normalized ratio; SAT, subcutaneous adipose tissue; SM, skeletal muscle volume; TAT, total adipose tissue; VAT, visceral adipose tissue.

Volumes normalized to the slice number of the abdominal cavity.